TRPV1 affects extracellular matrix (ECM), epithelial-mesenchymal transition EMT (EMT), tumor angiogenesis, inflammation, and P53 pathways in the regulation of CSCC (Figure 5C). The gene discussed is TP53; the disease is neoplasm.